Analysts' average 12-month price target for Satellos Bioscience Common Stock is $20.
Get informed when a big investor buys or sells
+ Follow$10.01
3 analysts in the last 4 months
High: $23 | Low: $18
No recommendations in the last 4 months.
As of the most recent data, MSLE shows a target price of $20. Scroll down for historical charts and peer comparison views.
If Satellos Bioscience Common Stock moved to the average analyst target of $20, shares would be roughly 96.5% higher than $10.01. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Satellos Bioscience Common Stock's earnings trajectory.
Besides this target price page, Stockcircle has Satellos Bioscience Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $20) with ownership activity and broader fundamentals.